Sign in
Taking people in FinlandPhase 2

Tests a new PET scan for spotting colon cancer spread to nearby lymph nodes

Tests a PET scan for finding colon cancer in nearby lymph nodes in adults.

Key facts

Who runs it
Turku University Hospital
Where
Turku, FinlandSee the site
Registry title
Diagnostic efficacy of 18F-FAPI-74 PET/CT in patients with colon cancer
Status
Recruiting
Phase
Phase 2
People taking part
100 people, planned
Started
14 Oct 2024
Planned end
1 Aug 2026
Type of study
Interventional
Record updated
20 August 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with primary colon cancer who may have spread to nearby lymph nodes or elsewhere, to test how well an 18F-FAPI-74 PET/CT scan finds it.

Age
18 years or older
Sex
All sexes can join
Disease stage
Primary colon cancer with suspected spread to lymph nodes in the abdomen on a CT scan before surgery; or cancer spread that may be treatable; or suspected spread or return of cancer on CT and/or a raised CEA level during follow-up
Biomarker or test result
A raised carcinoembryonic antigen (CEA) level is one way to join, during cancer follow-up

Main reasons for not taking part

  • Disabled people, children, prisoners
  • Pregnant or breast-feeding women
  • Cannot understand the purpose of the study
  • Medical conditions that rule out a whole body PET-CT

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Patients with primary colon cancer with suspicion of mesenteric lymph node metastases in computed tomography before primary cancer operation
  • Patients with primary colon cancer with potentially curable metastases
  • Patients with suspected metastasis or local recurrence in computed tomography and/or elevated carcinoembryonic antigen (CEA) in cancer surveillance
  • WHO performance score 0-2
  • Patient signs informed consent form after receiving written information

Who cannot take part

  • Medical conditions prohibiting whole body PET-CT
  • Vulnerable study subjects such as described in Finnish law clinical studies (disabled, children, pregnant or breast-feeding women, prisoners) will not be included
  • Patient is not able to understand purpose of study

Where in Finland

  • Turku University HospitalTurku, FinlandTaking people

About the trial

What the trial wants to find out

To assess the accuracy of 18F-FAPI-74 PET/CT in detection of local lymph node metastasis in patients with primary colon cancer

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Official title
Diagnostic efficacy of 18F-FAPI-74 PET/CT in patients with colon cancer
Plain-language title
Tests a new PET scan for spotting colon cancer spread to nearby lymph nodesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
20 August 2024